Shenfu Injection Mediated NLRP3/Caspase 1 Through (R)-Norcoclaurinee Alleviates Sepsis-Induced Cognitive Dysfunction
Xinqiang Liu,Hongguang Ding,Miner Chen,Xusheng Li,Yan Xiao,Yongli Han,Hongke Zeng
DOI: https://doi.org/10.2147/jir.s481171
IF: 4.5
2024-10-15
Journal of Inflammation Research
Abstract:Xinqiang Liu, 1, &ast Hongguang Ding, 2, &ast Miner Chen, 1, &ast Xusheng Li, 2 Yan Xiao, 1 Yongli Han, 1 Hongke Zeng 1 1 Department of Intensive Care Medicine, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, 510800, People's Republic of China; 2 Department of Emergency Medicine, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, 510800, People's Republic of China &astThese authors contributed equally to this work Correspondence: Hongke Zeng, Department of Intensive Care Medicine, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, No. 106, Zhongshan 2nd Road, Guangzhou, People's Republic of China, 510080, Tel/Fax +8602083827812-60810, Email Background: Shenfu injection (SF) has demonstrated its potential to enhance cellular immunity and induce clinical regression in patients suffering from sepsis or infectious shock. However, the therapeutic effect of SF on sepsis-induced cognitive dysfunction (SAE) and the mechanisms involved are still unclear. We aimed to investigate the mechanism of SF in mice with SAE. Methods: Sepsis was constructed by caecal ligation and puncture. Mice were injected intraperitoneally with SF or NLRP3 inhibitor. The hippocampus injury of brain tissues was evaluated, and the levels of inflammatory cytokines (IL-1β, IL-18) and NLRP3 and Caspase 1 were measured. The active ingredients of SF were analyzed using network pharmacology, and molecular docking of the active ingredients of SF with NLRP3 and Caspase 1 was performed. BV-2 cells were treated with LPS or norcoclaurine. CCK-8 detected the cell viability, and the levels of inflammatory cytokines and NLRP3 and Caspase 1 were measured. Results: SF and NLRP3 inhibitor increased survival rate and the number of crossing the platform and decreased the escape latency time of sepsis mice. Moreover, SF and NLRP3 inhibitor improved neuronal damage and apoptosis in hippocampus of sepsis mice. In addition, SF and NLRP3 inhibitor reduced the levels of inflammatory cytokines, as well as inflammasomes in sepsis mice. There were 43 active ingredients in SF. Among them, 22 were Renshen and 21 were Fuzi. Renshen and Fuzi, the main active components of SF, form a complex regulatory network with NLRP3 and Caspase 1. (R)-norcoclaurine was most closely bound to NLRP3 with binding energy of − 7.2 kJ·mol − 1 , ignavine was most closely bound to Caspase 1 with binding energy of − 8.3 kJ·mol − 1 . Norcoclaurine increased the cell viability and decreased inflammation and pyroptosis. Conclusion: SF regulated NLRP3/Caspase 1 through (R)-norcoclaurinee to prevent SAE. Keywords: shenfu injection, NLRP3, caspase 1, pyroptosis, sepsis-associated encephalopathy Sepsis-associated encephalopathy (SAE) is a serious and frequently encountered complication of sepsis, 1 which could lead to acute cognitive and consciousness disorders. 2 SAE is linked to increased mortality, decreased quality of life, and long-term neurological complications, ranging from 9% to 76% in patients with SAE diagnosed with sepsis progression. 3 The pathogenesis of SAE involves neuroinflammatory response, neurotransmitter dysfunction, destruction of blood-brain barrier, and abnormal blood flow regulation. 4 At present, the treatment of SAE is mainly symptomatic. Lack of specific treatment plans and insufficient understanding of the underlying mechanism of the disease are the reasons for poor prognosis of sepsis patients. 5 Therefore, it is of great significance to explore the treatment and underlying mechanisms of SAE, as well as implement preventive measures to reduce its occurrence and lower the incidence rate, so as to improve the prognosis of sepsis patients. Herbal injections contain a large number of hydrophilic components, and an in-depth understanding of their chemical composition, both qualitatively and quantitatively, is important to ensure the safety of their clinical use. 6 As a novel and promising option for the treatment of sepsis, herbal injections are widely used in China. 7 Shenfu injection (SF) derived from traditional Chinese medicine (TCM), which prepared from red ginseng and processed aconite root, is widely used in China for sepsis and cardiovascular diseases. 8,9 SF has various anti-inflammatory, anti-apoptotic, antioxidant and innate immunomodulatory effects. 10–12 These pharmacological effects may be attributed to the active constituents of the c -Abstract Truncated-
immunology